Time-dependent effects of ischaemia on neuropeptide y mechanisms in pig renal vascular control in vivo

Acta Physiologica Scandinavica

Volumn 161, Issue 3, 1997, Pages 327-338

  Malmström, Rickard E ^a   Lundberg, J M ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

ATP; BIBP 3226; Ischaemia; Kidney; Neuropeptide Y; Noradrenaline; Vasoconstriction; Y1 receptor antagonist

Indexed keywords

KETAMINE; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE Y; NORADRENALIN; PENTOBARBITAL; PEPTIDE YY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; EXOCYTOSIS; HEART MUSCLE ISCHEMIA; IMMUNOREACTIVITY; IN VIVO STUDY; NERVE STIMULATION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; SWINE; SYMPATHETIC NERVE;

EID: 0031416809     PISSN: 00016772     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-201X.1997.00238.x     Document Type: Article

References (39)

1. Baker, P.F. & Knight, D.H. 1978. Calcium-dependent exocytosis in bovine adrenal medullary cells with leaky plasma membranes. Nature 276, 620-622.
2. Clozel, M., Löfflcr, B.M. & Gloor, H. 1991. Relative preservation of the responsivencss to endothelin-1 during reperfusion following renal ischemia in the rat. J Cardiovasc Pharmacol 17(suppl. 7), S313-S315.
3. 6, receptors and the distribution and properties of an extended family ot ATP-gated ion channels. J Neurosci 16, 2495-2507.
4. Conger, J.D. & Weil, J.V. 1995. Abnormal vascular function following ischemia-reperfusion injury. J Invest Med 43, 431-442.
5. De Potter, W.P., Kurzawa, R., Miserez, B. & Coen, E.P. 1995. Evidence against differential release of notadrenaline, neuropeptide Y and dopamine-β-hydroxylase from adrenergic nerves in the isolated perfused sheep spleen. Synapse 19, 67-76.
6. De Potter, W.P., Partoens, P., Schoups, A., Llona, I. & Coen, E.P. 1997. Noradrenergic neurons release both noradrenaline and neuropeptide Y from a single pool: the large dense cored vesicles. Synapse 25, 44-55.
7. Devos, C., Robberecht, P., Nokin, P., Waelbroeck, M., Clinet, M., Camus, J.C., Beaufort, P., Schoenfeld, P. & Christophe, J. 1985. Uncoupling between beta-adrenoceptors and adenylate cyclase in dog ischemic myocardium. NaunynSchmiedeberg's Arch Pharmacol 331, 71-75.
8. Eberlein, G.A., Eysselein, V.E., Schaeffer, M., Layer, P., Grandt, D., Goebell, H., Niebel, E., Davis, M., Lee, T.D., Shively, J.E. & Reeve, J.R., Jr 1989. A new molecular form of PYY: structural characterization of human PYY (3-36) and PYY (1-36). Peptides 10, 797-803.
9. Freissmuth, M., Schütz, W., Weindlmayer-Göttel, M., Zimpfer, M. & Spiss, C.K. 1987. Effects of ischemia on the canine myocardial β-adrenoceptor-linked adenylate cyclase system. J Cardiovasc Pharmacol 10, 568-574.
10. Fried, G., Lundberg, J.M. & Theodorsson-Norheim, E. 1985. Subcellular storage and axonal transport of neuropeptide Y (NPY) in relation to catecholamines in the cat. Acta Physiol Scand 125, 145-154.
11. Fukasawa, K.M., Fukasawa, K. & Harada, M. 1978. Dipeptidyl aminopeptidase IV, a glycoprotein from pig kidney. Biochem Biophys Acta 535, 161-166.
12. Fukasawa, K.M., Fukasawa, K., Hiraoka, B.Y. & Harada, M. 1981. Comparison of dipeptidyl peptidase IV prepared from pig liver and kidney. Biochem Biophys Acta 657, 179-189.
13. Haass, M., Hock, M., Richardt, G. & Schömig, A. 1989. Neuropeptide Y differentiates between exocytotic and nonexocytotic noradrenaline release in guinea-pig heart. Naunyn-Schmiedeberg's Arch Pharmacol 340, 509-515.
14. Hooper, N.M., Hryszko, J. & Turner, A.J. 1990. Purification and characterization of pig kidney aminopeptidase P. A glycosyl- phosphatidylinositol-anchored ectoenzyme. Biochem J 267, 509-515.
15. Kaijser, L., Pernow, J., Berglund, B., Grubbström, J. & Lundberg, J.M. 1994. Neuropeptide Y release from human heart is enhanced during prolonged exercise in hypoxia. J Appl Physiol 76, 1346-1349.
16. 2 purinoceptor to ATP revealed by changing extracellular pH. Br J Pharmacol 117, 1371-1373.
17. Levi, G. & Raiteri, M. 1993. Carrier-mediated release of neurotransmitters. Trends Neurosci 16, 415-419.
18. Lieberthal, W., Wolf, E.F., Rennke, H.G., Valeri, C.R. & Levinsky, N.G. 1989. Renal ischemia and reperfusion impair endothelium-dependent vascular relaxation. Am J Physiol 256, F894-F900.
19. Lundberg, J.M. 1996. Pharmacology of cotransmission in the autonomie nervous system: integrative aspects on amines, neuropeptides, adenosine triphosphate, amino acids and nitric oxide. Pharmacol Rev 48, 113-178.
20. 1 receptor antagonist BIBP 3226. Br J Pharmacol 116, 2971-2982.
21. Lundberg, J.M., Rudehill, A., Sollevi, A., Fried, G. & Wallin, G. 1989. Co-release of neuropeptide Y and noradrenaline from pig spleen in vivo: importance of subcellular storage, nerve impulse frequency and pattern, feedback regulation and resupply by axonal transport. Neuroscience 28, 475-486.
22. 1 receptor antagonist SR 120107A on sympathetic vascular control in pigs in vivo. Naunyn-Schmiedeberg's Arch Pharmacol 354, 633-642.
23. 1 receptor mediated sympathetic vasoconstriction in pigs in vivo. Eur J Pharmacol 305 145-154.
24. Matthys, E., Patton, M.K., Osgood, R.W., Venkatachalam, M.A. & Stern, J.H. 1983. Alterations in vascular function and morphology in acute ischemic renal failure. Kidney Int 23, 717-724.
25. Medeiros, M.S. & Turner, A.J. 1994. Post-secretory processing of regulatory peptides: the pancreatic polypeptide family as a model example. Biochimie 76, 283-287.
26. Mentlein, R., Dahms, P., Grandt, D. & Krüger, R. 1993. Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV. Regul Pept 49, 133-144.
27. 2, NPY and angiotensin II receptors. Naunyn-Schmiedeberg's Arch Pharmacol 340, 379-385.
28. Pruneau, D. & Bélichard, P. 1993. Endothelium-dependent control of vascular tone in the rabbit kidney after ischemia and reperfusion. Eur J Pharmacol 231, 215-221.
29. 1 receptor antagonist: BIBP3226. Eur J Pharmacol 271, R11-R13.
30. Schulz, R., Sakane, Y., Berry, C. & Ghai, R. 1991. Characterization of neutral endopeptidase 3.4.24.11. (NEP) in the kidney: comparison between normotensive, genetically hypertensive and experimentally hypertensive rats. J Enzym Inhib 4, 347-358.
31. Schömig, A., Dart, A.M., Dietz, R., Mayer, E. & Kübler, W. 1984. Release of endogenous catecholamines in the ischemic myocardium of the rat. Circ Res 55, 689-701.
32. Schömig, A., Dart, A.M., Dietz, R., Mayer, E. & Kübler, W. 1985. Paradoxical role of neuronal uptake for the locally mediated release of endogenous noradrenaline in the ischemic myocardium. J Cardiovasc Pharmacol 7 (suppl. 5), s40-s44.
33. Schömig, A., Richardt, G. & Kurz, T. 1995. Sympathoadrenergic activation of the ischemic myocardium and its arrhythmogenic impact. Herz 20, 169-186.
34. Serradeil-Le Gal, C., Valette, G., Rouby, P.E., Pellet, A., Villanova, G., Foulon, L., Lespy, L., Neliat, G., Chambon, J.P., Maffrand, J.P. & Le Fur, G. 1994. SR 120107A and SR 120819A: two potent and selective orally-effective antagonists for NPV Y1 receptors. Soc Neurosci Abstr 20, 907.
35. Sidorowicz, W., Szechinski, J., Canizaro, P.C. & Behal, F.J. 1984. Cleavage of the ARG1-PRO2 bond of bradykinin by a human lung peptidase: isolation, characterization, and inhibition by several β-lactam antibiotics. Proc Soc Exp Biol Med 175, 503-509.
36. Stark, R.D. 1968. Conductance or resistance? Nature 217, 779.
37. Stephenson, S.L. & Kenny, A.J. 1987. Metabolism of neuropeptides. Hydrolysis of the angiotensins, bradykinin, substance P and oxytocin by pig kidney microvillar membranes. Biochem J 241, 237-247.
38. Theodorsson-Norheim, E., Hemsén, A. & Lundberg, J.M. 1985. Radioimmunoassay for neuropeptide Y (NPY): Chromatographic characterization ot immunoreactivity in plasma and tissue extracts. Scand J Clin Lab Invest 45, 355-365.
39. Vatner, D.E., Young, M.A., Knight, D.R. & Vatner, S.F. 1990. β-receptors and adenylate cyclase: comparison of nonischemic, ischemic and postmortem tissue. Am J Physiol 258, H140-H144.